Inhibikase Therapeutics shares owned by Tower Research Capital
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $13k | 6.5k | 2.05 |
| 2025-09-30 | $11k | 7.0k | 1.62 |
| 2025-06-30 | $195 | 100 | 1.95 |
| 2024-09-30 | $5.3k | 4.1k | 1.30 |
| 2024-06-30 | $6.9k | 5.7k | 1.21 |
| 2024-03-31 | $6.0k | 2.8k | 2.16 |
| 2023-09-30 | $3.1k | 2.2k | 1.39 |
| 2023-06-30 | $7.2k | 2.0k | 3.61 |